Skip to main content
. 2017 May 16;29(5):813–818. doi: 10.1589/jpts.29.813

Table 2. Menstrual characteristics of participants.

Control
(n=46)
Medication
(n=46)
Taping
(n=33)
Menarche age 12.0 ± 1.3 12.0 ± 0.9 12.3 ± 1.0
Menstrual cycle
<20 days 6 (35.3) 7 (41.2) 4 (23.5)
<25 days 8 (41.2) 7 (36.8) 4 (21.1)
<30 days 15 (31.3) 18 (37.5) 15 (31.3)
>30 days 11 (44.0) 9 (36.0) 5 (20.0)
Irregularity 6 (37.5) 5 (31.3) 5 (31.3)
Menstrual duration
3–5 days 23 (33.3) 22 (31.9) 24 (34.8)
over 6 days 23 (42.6) 23 (42.6) 8 (14.8)
Days of severe pain
1–2 days before 3 (27.3) 5 (45.5) 3 (27.3)
First 1–2 days 28 (35.9) 32 (41.0) 18 (23.1)
2–3 days 7 (33.3) 7 (33.3) 7 (33.3)
Whole period 7 (53.8) 1 (7.7) 5 (38.5)
Frequency of medication
Once for the whole period 18 (31.0) 27 (46.6) 13 (22.4)
Once per day 1 (33.3) 1 (33.3) 1 (33.3)
Twice for the whole period 6 (42.9) 5 (35.7) 3 (21.4)
Over twice per day 0 (0) 3 (75.0) 1 (25.0)
None 21 (45.7) 10 (21.7) 15 (32.6)

Data are expressed as mean ± standard deviation or N (%).